 NEW YORK, June 22, 2021 PRNewswire -- Oramed Pharmaceuticals Inc. NASDAQ: ORMP TASE: ORMP a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it is set to join the U.S. small cap Russell 2000 and broad-market Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, 2021, according to a preliminary list of additions posted by FTSE Russell on June 4, 2021. Annual Russell indexes reconstitution captures the 4,000 largest U.S. stocks as of May 7, 2021, ranking them by total market capitalization. 